ANAVEX LIFE SCIENCES CORP (AVXL)
US0327973006 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 61.61% | N/A 180.22% | N/A 31.00% | N/A 22.65% | N/A 62.28% | ||||||||||||
| EBITDA YoY % growth | -3.11M | -2.97M 4.50% | -7.11M -139.39% | -15.59M -119.27% | -15.68M -0.58% | N/A | N/A | N/A | N/A | N/A | N/A -23.91% | N/A -31.58% | N/A 294.67% | N/A 243.84% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -3.11M | -2.97M 4.50% | -7.11M -139.39% | -15.59M -119.27% | -15.68M -0.58% | -19.33M -23.28% | -29.11M -50.59% | -31.09M -6.80% | -42M -35.09% | -50.99M -21.40% | -55.76M -9.35% | N/A -1.99% | N/A -13.54% | N/A 557.38% | N/A 74.28% | N/A 213.38% | N/A 31.74% | N/A 22.82% | N/A 63.60% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A 69.44% | -0.42 -274.33% | N/A 10.14% | N/A | -0.54 -43.08% | -0.45 16.67% | -0.53 -17.78% | -0.62 -16.98% | -0.60 3.23% | -0.52 13.33% | N/A -22.92% | N/A 546.01% | N/A 211.63% | N/A 43.51% | N/A 21.76% | N/A 10.12% | N/A 48.27% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.19 -76.18% | -0.20 -56.92% | -0.23 -67.57% | -0.18 -31.14% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.14 -16.67% | -0.17 | 0.03 | 15.96% |
| Q3 2024 Q2Q % growth | -0.14 | -0.16 | 0.02 | 14.22% |
| Q2 2024 Q2Q % growth | -0.13 23.53% | -0.11 | -0.02 | -15.86% |
| Q1 2024 Q2Q % growth | -0.11 35.29% | -0.15 | 0.04 | 25.63% |
| Q4 2023 Q2Q % growth | -0.12 33.33% | -0.15 | 0.03 | 19.79% |
| Q3 2023 Q2Q % growth | -0.14 12.50% | -0.17 | 0.03 | 17.65% |
| Q2 2023 Q2Q % growth | -0.17 -21.43% | -0.19 | 0.02 | 10.72% |
| Q1 2023 Q2Q % growth | -0.17 -21.43% | -0.19 | 0.02 | 12.28% |
| Q4 2022 Q2Q % growth | -0.18 -20.00% | -0.17 | -0.01 | -8.93% |
| Q3 2022 Q2Q % growth | -0.16 -14.29% | -0.16 | 0.00 | -3.20% |
| Q2 2022 Q2Q % growth | -0.14 -16.67% | -0.17 | 0.03 | 18.06% |
| Q1 2022 Q2Q % growth | -0.14 -16.67% | -0.16 | 0.02 | 11.45% |
| Q4 2021 Q2Q % growth | -0.15 -50.00% | -0.15 | 0.00 | -0.27% |
| Q3 2021 Q2Q % growth | -0.14 -27.27% | -0.14 | 0.00 | -2.43% |
| Q2 2021 Q2Q % growth | -0.12 | -0.15 | 0.03 | 17.44% |
| Q1 2021 Q2Q % growth | -0.12 | -0.11 | -0.01 | -6.95% |
| Q4 2020 Q2Q % growth | -0.10 -42.86% | -0.13 | 0.03 | 23.11% |
| Q3 2020 Q2Q % growth | -0.11 21.43% | -0.14 | 0.03 | 21.57% |
| Q2 2020 Q2Q % growth | -0.12 29.41% | -0.16 | 0.04 | 24.10% |
| Q1 2020 Q2Q % growth | -0.12 25.00% | -0.14 | 0.02 | 15.97% |
| Q4 2019 Q2Q % growth | -0.07 46.15% | -0.15 | 0.08 | 54.25% |
| Q3 2019 Q2Q % growth | -0.14 -133.33% | -0.17 | 0.03 | 19.26% |
| Q2 2019 Q2Q % growth | -0.17 -54.55% | -0.14 | -0.03 | -19.05% |
| Q1 2019 Q2Q % growth | -0.16 | -0.13 | -0.03 | -20.66% |
| Q4 2018 Q2Q % growth | -0.13 | -0.11 | -0.02 | -15.86% |
| Q3 2018 Q2Q % growth | -0.06 | -0.11 | 0.05 | 43.07% |
| Q2 2018 Q2Q % growth | -0.11 | -0.10 | -0.01 | -7.84% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |